Vote Now
Your vote is important. You may vote online or by phone.
To vote by phone, dial 866-217-7017.
The secure way to view our meeting materials, annual documents, and to vote your shares.
View the enhanced document outlining key information about the upcoming shareholder meeting.
View an enhanced version of the report summarizing our financial and operational performance for the year 2022.
You may request paper copies of the proxy materials by phone, email or online.
To request by phone, dial 866-648-8133.
Your vote is important. You may vote online or by phone.
To vote by phone, dial 866-217-7017.
April 27, 2023
9:00 a.m. Mountain Time
Note: You must register to be eligible to participate in the meeting.
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than $1 billion in net sales, NuVasive operates in more than 50 countries serving surgeons, hospitals, and patients. For more information, please visit nuvasive.com.
Globus Medical, Inc. (NYSE: GMED) is a leading musculoskeletal solutions company based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders. Additional information can be accessed at www.globusmedical.com.